During the past decade, Gleneagles Global Hospitals conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 7 clinical trials were completed, i.e. on average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gleneagles Global Hospitals" #1 sponsor was "Gilead Sciences" with 5 trials, followed by "Galapagos NV" with 4 trials sponsored, "Allergan" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Mast Therapeutics, Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gleneagles Global Hospitals" #1 collaborator was "Gilead Sciences" with 4 trials as a collaborator, "Cadila Pharnmaceuticals" with 1 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator, "Indian Society of Critical Care Medicine" with 1 trials as a collaborator and "Population Health Research Institute" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Gleneagles Global Hospitals" are "Crohn's Disease" (2 trials), "HBV" (2 trials), "Ulcerative Colitis" (2 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Cardiovascular Diseases" (1 trials). Many other conditions were trialed in "Gleneagles Global Hospitals" in a lesser frequency.

Most popular intervention types in "Gleneagles Global Hospitals" are "Drug" (15 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Filgotinib" (5 trials), "Placebo" (2 trials), "Placebo to match filgotinib" (2 trials), "TAF" (2 trials) and "TAF Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Gleneagles Global Hospitals" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Gleneagles Global Hospitals". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 10 completed trials in Gleneagles Global Hospitals, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Gleneagles Global Hospitals, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".